OTCMKTS:PHGUF Pharming Group (PHGUF) Stock Price, News & Analysis $0.85 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$0.85▼$0.8550-Day Range$0.81▼$0.9552-Week Range$0.81▼$1.40VolumeN/AAverage Volume155 shsMarket Capitalization$553.05 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsHeadlinesShort InterestStock AnalysisChartEarningsHeadlinesShort Interest Get Pharming Group alerts: Email Address Ad DTIHeard about the 72-Hour Profit Surge? Read this…One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge…Click here now to get all the details. About Pharming Group Stock (OTCMKTS:PHGUF)Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks. It also engages in the development of leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome; OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE; and alpha-glucosidase therapy for the treatment of Pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. is headquartered in Leiden, the Netherlands.Read More PHGUF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PHGUF Stock News HeadlinesJuly 19, 2024 | finance.yahoo.comPharming Group to report second quarter and first half 2024 financial results on August 1May 21, 2024 | finance.yahoo.comPharming Group reports on results of the 2024 Annual General Meeting of ShareholdersJuly 26, 2024 | DTI (Ad)We’re in a code red crisis and 99% of Americans are clueless Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES! May 8, 2024 | bizjournals.comOrchard to lose out on milestone payments as Pharming Group ends collabApril 28, 2024 | wsj.comPharming Group N.V.April 19, 2024 | finance.yahoo.comPharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025April 18, 2024 | finance.yahoo.comPharming Group announces the placement of €100 million convertible bonds due 2029April 8, 2024 | markets.businessinsider.comOptimistic Buy Rating on Pharming Group Backed by Promising Leniolisib Trials and Strategic Market ExpansionJuly 26, 2024 | DTI (Ad)We’re in a code red crisis and 99% of Americans are clueless Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES! April 8, 2024 | finanznachrichten.dePharming Group N.V.: Pharming announces completion of enrollment in pediatric clinical trial of leniolisibApril 4, 2024 | finance.yahoo.comPharming Group announces the 2024 Annual General Meeting of ShareholdersApril 3, 2024 | finance.yahoo.comPharming Group to participate in April investor conferencesMarch 17, 2024 | finance.yahoo.comPharming Group N.V. (AMS:PHARM) Analysts Are Pretty Bullish On The Stock After Recent ResultsMarch 16, 2024 | finance.yahoo.comPharming Group Full Year 2023 Earnings: US$0.015 loss per share (vs US$0.021 profit in FY 2022)March 15, 2024 | markets.businessinsider.comPharming Group’s Strong Financial Performance and Growth Potential Merit Buy RatingFebruary 29, 2024 | finance.yahoo.comPharming Group to report fourth quarter and full year 2023 financial results on March 14February 20, 2024 | uk.investing.comPharming Group NV (PHAR)January 12, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG) and Pharming Group (OtherPHGUF)See More Headlines Receive PHGUF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/08/2024Today7/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:PHGUF Previous SymbolOTC:PHGUF CUSIPN/A CIKN/A Webwww.pharming.com Phone(171) 524-7400Fax31-0-71-524-7445Employees332Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-10,550,000.00 Net Margins-4.00% Pretax Margin-4.90% Return on Equity-4.54% Return on Assets-2.15% Debt Debt-to-Equity Ratio0.14 Current Ratio1.43 Quick Ratio1.16 Sales & Book Value Annual Sales$245.32 million Price / SalesN/A Cash Flow$0.01 per share Price / Cash Flow84.56 Book Value$0.34 per share Price / Book2.49Miscellaneous Outstanding SharesN/AFree FloatN/AMarket Cap$553.05 million OptionableNot Optionable Beta1.13 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesDr. Sijmen de Vries M.B.A. (Age 65)M.D., President, CEO & Executive Director Comp: $1.18MMr. Jeroen Wakkerman (Age 55)Chief Financial Officer Ms. Mireille Sanders M.Sc. (Age 56)Chief Operations Officer Susanne EmbletonInvestor Relations ManagerMr. Ruud Van Outersterp (Age 60)Chief Ethics & Compliance Officer Dr. Anurag Relan M.D. (Age 52)MPH, Chief Medical Officer Mr. Stephen Toor (Age 53)Chief Commercial Officer & GM Americas Dr. Alexander Breidenbach M.B.A.Chief Business OfficerDr. Bruno M. L. Giannetti (Age 72)Consultant More ExecutivesKey CompetitorsRocket PharmaceuticalsNASDAQ:RCKTProtagonist TherapeuticsNASDAQ:PTGXMaravai LifeSciencesNASDAQ:MRVICatalyst PharmaceuticalsNASDAQ:CPRXArvinasNASDAQ:ARVNView All Competitors PHGUF Stock Analysis - Frequently Asked Questions How have PHGUF shares performed this year? Pharming Group's stock was trading at $1.1750 at the start of the year. Since then, PHGUF shares have decreased by 27.9% and is now trading at $0.8477. View the best growth stocks for 2024 here. How were Pharming Group's earnings last quarter? Pharming Group (OTCMKTS:PHGUF) issued its quarterly earnings data on Wednesday, May, 8th. The biotechnology company reported ($0.02) EPS for the quarter. The biotechnology company had revenue of $55.59 million for the quarter. Pharming Group had a negative net margin of 4.00% and a negative trailing twelve-month return on equity of 4.54%. How do I buy shares of Pharming Group? Shares of PHGUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:PHGUF) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharming Group Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharming Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
